Can Real Time Monitoring & Support Increase Medication Adherence v1.4
Research type
Research Study
Full title
Randomised Control Trial to Assess the impact on Medication Adherence in Patients with Type 2 Diabetes mellitus, with and without Reminders, using an Intelligent Packaging Solution
IRAS ID
241281
Contact name
Parag Singhal
Contact email
Sponsor organisation
MARsoftware Limited
Duration of Study in the UK
0 years, 4 months, 1 days
Research summary
Can Real Time Monitoring combined with a Patient Support Network increase Medication Adherence for Patients with Type 2 Diabetes mellitus?
There is considerable academic literature that suggests patients do not take their medication as prescribed for example WHO (2003) puts this number at 50%. IMS (2016) Health estimate the global annual cost at US$500 billion, and in the UK NICE (2015) estimate that hospital admissions alone cost the NHS £527 million annually; the knock on costs to Social Care is multiples of that. The economic and patient costs therefore require innovative research in this area.
What? We will test a new CE certified medical aid on patients with Type 2 Diabetes mellitus with a known adherence issue. Patients will be prescribed their usual medication. However the medication will be dispensed in the YOURmeds 'intelligent' packaging by experienced pharmacists. This will enable the researchers to know when the medication was accessed. If it was not, then each patient's support network, created by the patient, will be automatically alerted in real time, to remind the patient to take their meds. There is no change required in patient behaviour or their medication.
Eligibility criteria are that patients have to be over 18 years old, able to give informed consent, suffering from Type 2 Diabetes mellitus, and must be on medication.
Patients will be recruited via GP Surgeries and three primary sites have been identified as The Heggarty Clinic in Weston-super-Mare, Waterside Medical Practice (Hayling Island ) ANOTHER. Between these 3 sites, 158 patients are required.
The study is a RCT step wedge design. Overall length is 3 months with patients randomised into three clusters. They simply take their medication from different packaging, rather than their existing nomad. Pharmacists will dispense and deliver the medication directly to each patient. Adherence will be recorded remotely.REC name
Yorkshire & The Humber - South Yorkshire Research Ethics Committee
REC reference
18/YH/0062
Date of REC Opinion
9 Feb 2018
REC opinion
Favourable Opinion